Literature DB >> 7977949

Aggressive papillary tumor of middle ear/temporal bone and adnexal papillary cystadenoma. Manifestations of von Hippel-Lindau disease.

M J Gaffey1, S E Mills, J C Boyd.   

Abstract

The occurrence of an aggressive papillary middle ear/temporal bone tumor (APMET) and a benign adnexal papillary tumor of probable mesonephric origin (APMO) in a patient with von Hippel-Lindau disease (VHL) is reported. Histologically, both tumors were identical to papillary cystadenomas of the epididymis and broad ligament of probable mesonephric derivation. A comprehensive literature review showed that including the current case, seven of 46 (15%) documented cases of APMET and four of four (100%) cases of APMO arose in patients with VHL. Given an estimated minimum birth incidence of 1/36,000, a one-sample test of binomial proportion using the exact method establishes that the association of APMET and APMO with VHL is highly significant (p = 1.4 x 10(-24) and 1 x 10(-18), respectively). The data indicate that APMET and APMO may represent major visceral manifestations of VHL. Accordingly, in the presence of one of these tumors strong consideration should be given to the diagnosis of VHL, given either the presence of another major component of VHL or documentation of VHL in at least one consanguineous relative.

Entities:  

Mesh:

Year:  1994        PMID: 7977949     DOI: 10.1097/00000478-199412000-00009

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

1.  An analysis of five clear cell papillary cystadenomas of mesosalpinx and broad ligament: four associated with von Hippel-Lindau disease and one aggressive sporadic type.

Authors:  Francisco F Nogales; Pablo Goyenaga; Ovidiu Preda; Alina Nicolae; Begoña Vieites; Maria Carmen Ruiz-Marcellan; Alberto Pedrosa; Maria J Merino
Journal:  Histopathology       Date:  2012-02-01       Impact factor: 5.087

2.  Adenomatous tumors of the middle ear and temporal bone: clinical, morphological and tumor biological characteristics of challenging neoplastic lesions.

Authors:  M Duderstadt; Christine Förster; H-J Welkoborsky; H Ostertag
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-24       Impact factor: 2.503

Review 3.  [Tumors of the inner ear and adjacent structures].

Authors:  J Schittenhelm
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

Review 4.  Differentiating imaging findings in primary and secondary tumors of the jugular foramen.

Authors:  Hubert Löwenheim; Andrei Koerbel; Florian H Ebner; Hidetaka Kumagami; Ulrike Ernemann; Marcos Tatagiba
Journal:  Neurosurg Rev       Date:  2005-11-09       Impact factor: 3.042

5.  Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: findings, results, and indications.

Authors:  H Jeffrey Kim; Marygrace Hagan; John A Butman; Martin Baggenstos; Carmen Brewer; Christopher Zalewski; W Marston Linehan; Russell R Lonser
Journal:  Laryngoscope       Date:  2012-10-15       Impact factor: 3.325

6.  Small papillary tumor in the saccule.

Authors:  Jiangping Zhang; Kimitaka Kaga; Qing Yin Zheng
Journal:  Int J Pediatr Otorhinolaryngol Extra       Date:  2007-06

7.  Deafness due to bilateral endolymphatic sac tumours in a case of von Hippel-Lindau syndrome.

Authors:  G Kempermann; H P Neumann; R Scheremet; B Volk; W Mann; J Gilsbach; R Laszig
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-09       Impact factor: 10.154

8.  Lipid cell tumors in two women with von Hippel-Lindau syndrome.

Authors:  Marnie Wagner; Hyacinth N Browne; W Marston Linehan; Maria Merino; Nabeel Babar; Pamela Stratton
Journal:  Obstet Gynecol       Date:  2010-08       Impact factor: 7.623

9.  Papillary cystadenoma of the fallopian tube not associated with von hippel-lindau disease: a case report.

Authors:  Jae Yeon Seok; Myunghee Kang; Jungsuk An; Hyunchul Kim; Kwang-Beom Lee; Hyun Yee Cho
Journal:  Korean J Pathol       Date:  2014-10-27

10.  A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.

Authors:  Heather Hampel; Robin L Bennett; Adam Buchanan; Rachel Pearlman; Georgia L Wiesner
Journal:  Genet Med       Date:  2014-11-13       Impact factor: 8.822

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.